iMedX

Atlanta, United States Founded: 2002 • Age: 24 yrs Acquired By Rapid Care
Revenue cycle management platform is provided to healthcare providers.

About iMedX

iMedX is a Healthcare company based in Atlanta (United States) founded in 2002 by Venkat Sharma, and was acquired by Rapid Care in June 2023. Revenue cycle management platform is provided to healthcare providers. iMedX has raised $22.28 million across 5 funding rounds from investors including Ventureast, RFE Investment Partners and Rapid Care. iMedX has completed 6 acquisitions, including Axcension, G2N and MedWrite. Its Indian entity Imedx Information Services Private Limited reported revenue of β‚Ή31.29 Cr. Its focus areas include HealthTech, Healthcare IT, Provider and Administrative Solutions. Its competitors include Centivo, Xifin and Infinx; 2 of its 3 listed competitors have raised funding.

Company details

iMedX was founded in 2002 in Atlanta, United States, and operates in the healthcare sector. A web and mobile-based platform is offered for revenue cycle management to hospitals and providers. Medical transcription and coding services are included among the solutions. Acquisitions such as G2N, Abacus Transcriptions, Medwrite, Superior Global Solutions, and National Medical Transcription have been completed. The 2015 ACG Atlanta Georgia Fast 40 award was received.

  • Headquarters Atlanta, United States
  • Founders Venkat Sharma
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website imedx.com
  • Social LinkedIn X Facebook
  • Acquired by Rapid Care (Jun 2023)
  • Legal Name Imedx Information Services Private Limited
  • Date of Incorporation 22 Feb, 2005
  • Jurisdiction Hyderabad, Telangana, India
Key Metrics
  • Indian entity revenue
    ₹31.29 Cr

    FY 2023 · +21% YoY

  • Indian entity net profit
    ₹3.15 Cr

    FY 2023 · 10% margin

  • Indian entity EBITDA
    ₹3.44 Cr

    FY 2023 · 11% margin

  • Total Equity Funding
    $22.28M (USD)

    in 5 rounds

  • Latest Funding Round
    $4.03M (USD), Series B

    Dec 2013

  • Investors
    Ventureast

    & 2 more

  • Investments & Acquisitions
    Axcension

    & 5 more

  • Acquired by
    Rapid Care

    (Jun 2023)

Funding Insights of iMedX

iMedX has successfully raised a total of $22.28M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $4.03 million completed in December 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $22.28M
  • Total Rounds 5
  • Last Round Series B β€” $4.03M
  • First Round $13.3M

    (Jul 2009)

  • Investors Count 2

All 5 funding rounds of iMedX with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2013$4.03MSeries B––
Oct 2011$950,000Series B––
–
Jan 2011$2.5MSeries B––
–
Sep 2010$1.5MSeries B–RFE Investment Partners
–
Jul 2009$13.3MSeries B––
–
Valuation history

3 investors in total: 3 institutional.

Investors in iMedX

iMedX has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Ventureast, RFE Investment Partners and Rapid Care.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Private equity investments are managed from the United States.
rfeip.comNew Canaan, United States
Venture capital investments in technology, healthcare, and clean environment sectors since 1997.
1997ventureast.netBengaluru, India
rapidcare.net
Premium access

Investor details for iMedX

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Imedx Information Services Private Limited (iMedX)

Imedx Information Services Private Limited is the primary company behind iMedX. The board of Imedx Information Services Private Limited currently have 2 directors; the longest-serving is Kshatrapati Bali Karan Singh, appointed in 2016. 15 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Kshatrapati Bali Karan Singh
DIN 07645604
Managing Director27 Oct 201610 yrsImedx Information Services Private Limited
Joseph Raymond D’Angelo
DIN 09760369
Director10 Oct 20224 yrsImedx Information Services Private Limited

People of iMedX

3 people are tracked at iMedX (3 in leadership).

NameRoleGroup
FounderLeadership
Alexander Zacher
Managing DirectorLeadership
Will Powers
Director Of SalesLeadership
Premium access

Complete people profiles for iMedX

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of iMedX

Figures of Imedx Information Services Private Limited, the primary company behind iMedX, for FY 2023. Revenue was ₹31.29 Cr (+21% year on year). Net profit was ₹3.15 Cr (10% margin). EBITDA was ₹3.44 Cr (11% margin). Revenue has grown at a compounded annual rate of -5% over three years and -2% over five years.

  • ₹31.29 CrRevenue · FY 2023 · +21% YoY
  • ₹3.15 CrNet profit · 10% margin
  • ₹3.44 CrEBITDA · 11% margin
  • ₹1.74 CrPaid-up capital
  • 126Employees (provident fund records)
  • -5%Revenue CAGR, 3 years
  • -2%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Imedx Information Services Private Limited are on its company page.

Premium access

Detailed financial statements for iMedX

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by iMedX

iMedX has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Axcension, G2N and MedWrite.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Vendor risk management solution provider
prevalent.netWarren, United States2004Jul 2019β€’β€’β€’β€’
Web-based applications and services are developed and delivered.
axcension.comSugar Land, United States2003Jul 2019β€’β€’β€’β€’
Medical dictation and transcription services are provided in Australia.
ozescribe.com.auMelbourne, Australia1999Jan 2016β€’β€’β€’β€’
Limited information is available on G2N's core activities.
g2n.orgSt. Louis, United States2015Dec 2015β€’β€’β€’β€’
Customized scientific and medical communication services are provided.
medwrite.comNewport Beach, United States2002Nov 2014β€’β€’β€’β€’
Established in 1996, operations are based in Cortland, United States.
theinneroffice.comCortland, United States1996Mar 2012β€’β€’β€’β€’
Premium access

Complete acquisition details for iMedX

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of iMedX

10 dated milestones of iMedX across 21 years, from founding to its latest funding, stage changes and deals.

  1. Founded iMedX is founded.
  2. Funding First funding round of $13.3M.
  3. Acquisition Acquires The Inner Office.
  4. Funding Latest funding round, Series B, of $4.0M.
  5. Acquisition Acquires MedWrite.
  6. Acquisition Acquires G2N.
  7. Acquisition Acquires OzeScribe.
  8. Acquisition Acquires Prevalent.
  9. Acquisition Acquires Axcension.
  10. Exit Acquired by Rapid Care.

Competitors of iMedX

iMedX has 3 listed competitors in our database, 2 of them funded. They include Centivo, Xifin and Infinx.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
centivo.com2017New York, United States$224M212
Provider of self funded health plan
xifin.com1997San Diego, United States$6M861
Cloud-based billing & revenue cycle management solutions for diagnostic service providers
infinx.com2010San Francisco, United States6,350
Revenue cycle management platform for healthcare is provided.
Premium access

Detailed competitors of iMedX

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of iMedX

The website of iMedX (imedx.com) receives about 6.9K visits a month.

  • Monthly visits
    6.9K

    ▼ 47.5% vs previous month

Similar websites

Websites whose visitors overlap most with iMedX. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
medicaltranscriptionservicecompany.com
medicaltranscriptionservicecompany.com
100%
#4,863,651–
alamo-trans.com
84%
View details
transcriptionplus.net
transcriptionplus.net
84%
–
wmtsv.com
wmtsv.com
83%
–
teletouchtranscriptionservices.com
teletouchtranscriptionservices.com
83%
–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 10 similar websites and full traffic analytics for iMedX

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 10 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as iMedX (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Imedx

Premium access

Complete news archive for iMedX

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about iMedX

iMedX was founded in 2002 and raised its 1st funding round 7 years after it was founded.

iMedX is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.

iMedX is a funded company, having raised a total of $22.28M across 5 funding rounds to date. The company's 1st funding round was a Series B of $13.3M, raised on Jul 2009.

The primary company behind iMedX, Imedx Information Services Private Limited, reported revenue of β‚Ή31.29 Cr for FY 2023, up 21% year on year.

iMedX was founded in 2002 in Atlanta, United States, and operates in the healthcare sector. A web and mobile-based platform is offered for revenue cycle management to hospitals and providers. Medical transcription and coding services are included among the solutions. Acquisitions such as G2N, Abacus Transcriptions, Medwrite, Superior Global Solutions, and National Medical Transcription have been completed. The 2015 ACG Atlanta Georgia Fast 40 award was received.

iMedX's top competitors include Centivo, Infinx and Xifin.

iMedX has made 6 acquisitions, including Axcension, G2N, and MedWrite.

iMedX has 3 investors. Key investors include Ventureast, RFE Investment Partners, and Rapid Care.

iMedX operates through Imedx Information Services Private Limited.

Yes. iMedX was acquired by Rapid Care in June 2023.

The legal entities of iMedX currently have 2 directors, including Kshatrapati Bali Karan Singh, Joseph Raymond D’Angelo.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available